Investor Visit

Smith & Nephew Plc
07 September 2005


Investor visit to Smith & Nephew Orthopaedics


7 September 2005


Smith & Nephew plc, (LSE: SN, NYSE: SNN), the global medical technology
business, will be holding a visit for institutional investors and analysts at
the global headquarters of the company's orthopaedics business in Memphis,
Tennessee, on Thursday 15 September 2005.

The visit will be hosted by Chief Executive, Sir Christopher O'Donnell, and Dave
Illingworth, President of Smith & Nephew Orthopaedics.  During the visit guests
will have the opportunity to meet senior management, visit the manufacturing
facilities and receive presentations from the heads of Orthopaedics' three
businesses, Reconstructive Implants, Trauma and Clinical Therapies.

Commenting on the visit, Sir Christopher O'Donnell said 'Smith & Nephew
Orthopaedics has consistently been the fastest growing orthopaedics business in
the world over the last few years and it will be a pleasure to show our guests
some of the exciting new developments which are fuelling our success.'

The main presentations of the event will be webcast live on Smith & Nephew's
corporate website at www.smith-nephew.com and will begin at 12 noon BST/7am EST
on Thursday 15 September 2005.  An archive of these presentations will be
available on the site shortly after the close.


Enquiries

Liz Hewitt                                    Tel:       [phone]
Group Director Corporate Affairs


About us

Smith & Nephew is a global medical technology business, specialising in
Orthopaedics, Endoscopy and Advanced Wound Management products.  Smith & Nephew
is a global leader in arthroscopy and advanced wound management and is one of
the fastest growing global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives.  The company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with high
standards of performance, innovation and trust.  The company has over 8,500
employees and operates in 33 countries around the world generating annual sales
of £1.25 billion.


Forward-Looking Statements

This press release contains certain 'forward-looking statements' within the
meaning of the US Private Securities Litigation Reform Act of 1995.  In
particular, statements regarding expected revenue growth and operating margins
discussed under 'Outlook' are forward-looking statements as are discussions of
our product pipeline.  These statements, as well as the phrases 'aim', 'plan',
'intend', 'anticipate', 'well-placed', 'believe', 'estimate', 'expect',
'target', 'consider' and similar expressions, are generally intended to identify
forward-looking statements.  Such forward-looking statements involve known and
unknown risks, uncertainties and other important factors (including, but not
limited to, the outcome of litigation, claims and regulatory approvals) that
could cause the actual results, performance or achievements of Smith & Nephew,
or industry results, to differ materially from any future results, performance
or achievements expressed or implied by such forward-looking statements.  Please
refer to the documents that Smith & Nephew has filed with the U.S. Securities
and Exchange Commission under the U.S. Securities Exchange Act of 1934, as
amended, including Smith & Nephew's most recent annual report on Form 20F, for a
discussion of certain of these factors.

All forward-looking statements in this press release are based on information
available to Smith & Nephew as of the date hereof.  All written or oral
forward-looking statements attributable to Smith & Nephew or any person acting
on behalf of Smith & Nephew are expressly qualified in their entirety by the
foregoing.  Smith & Nephew does not undertake any obligation to update or revise
any forward-looking statement contained herein to reflect any change in Smith &
Nephew's expectation with regard thereto or any change in events, conditions or
circumstances on which any such statement is based.


                      This information is provided by RNS
            The company news service from the London Stock Exchange